Elanco Animal Health announces Lilly’s agreement to acquire ChemGen Corp.
24 January 2012
Elanco, announced that Lilly has signed an agreement to acquire ChemGen Corp., a privately held bioscience company...
News
The latest news from the pharmaceutical industry. If you have a piece of news that you would like us to cover, please contact Pippa McCartney on +44(0) 1959 563311 or email us.
Novo Nordisk establishes type 1 diabetes R&D center in Seattle
24 January 2012
Novo Nordisk announced that the company will establish a type 1 diabetes R&D center in Seattle, US...
Bristol-Myers Squibb names Gerald L. Storch to Board of Directors
24 January 2012
Bristol-Myers Squibb Company announced that its Board of Directors has elected Gerald L. Storch to the Board...
Roche supports cancer care development program in Ethiopia
23 January 2012
Establishment of a program to improve basic cancer care in Ethiopia...
Novartis drug Signifor® recommended by CHMP
20 January 2012
If approved, Signifor would be the first approved medication targeting Cushing's disease...
FDA updates TYSABRI(R) (NATALIZUMAB) label to include anti-JCV antibody status as a PML risk factor
20 January 2012
The U.S. FDA has approved a product label change for TYSABRI...
CHMP recommends EU approval to update Novartis drug Glivec® label to include three year treatment for GIST patients after surgery
20 January 2012
Update of the Glivec® (imatinib)* label...
Merck resolves Vioxx® litigation in Canada
19 January 2012
Merck announced that it has entered into an agreement to resolve all claims related to Vioxx® in Canada...
Bristol-Myers Squibb announces charitable donation of $6.9 million to support cancer patients
19 January 2012
Donation of $6.9 million in 2011 to support the HealthWell Foundation...
B&W Tek to introduce spectral data acquisition software at SPIE’s BiOS & Photonics West Exhibits
19 January 2012
B&W Tek, Inc., is proud to introduce BWSpec™ 4.00...
Sandoz initiates two more Phase III biosimilar trials, reinforcing long-term global leadership commitment
19 January 2012
Sandoz announced that it has initiated two milestone Phase III clinical trials...
PAT supplement
This free to view PAT supplement is sponsored by Sartorius, Extrel, ABB, Bruker Optics and FOSS NIRSystems:
Company directory
ABB Analytical Measurements | Almac | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Daltonik GmbH | CAMO Software AS | CI Precision | Cisbio Bioassays | Colder Products Company | Expo Technologies, LLC. | Freeman Technology | GE Analytical Instruments | HACH LANGE GMBH | HORIBA Scientific | Hudson Robotics, Inc. | Natoli Engineering Company, Inc. | Peter Huber Kältemaschinenbau GmbH | Randox Pharma Services | Rapid Micro Biosystems | Smithers Viscient | Synbiosis | Syngene | Watson-Marlow Pumps Group |
Login to access exclusive content